7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one

We are 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one CAS:73942-87-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one
CAS.NO:73942-87-7
Synonyms:7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one
7,8-dimethoxy-1,3-dihydro-3-benzazepin-2-one
1,3-Dihydro-7,8-dimethoxy-2H-3-benzazepin-2-one
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 455.8±45.0 °C at 760 mmHg
Molecular Formula C12H13NO3
Molecular Weight 219.236
Flash Point 229.5±28.7 °C
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.546
 
Specification:
Appearance:White to beige powder
Assay:≥98.0%
Moisture:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ivabradine(CAS:155974-00-8) and Ivabradine hydrochloride(CAS:148849-67-6).

7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one


Related News: Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.1-Methylpiperazine Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.Isopropyl Chloroformate The mode of cooperation between domestic API companies and large international companies can lower the export threshold.443882-99-3 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.

Related Products
Product Name
2-Bromo-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone View Details
(S)-(+)-3-Hydroxytetrahydrofuran View Details
Enfuvirtide View Details
N,N’-Carbonyldiimidazole manufacturer Remdesivir manufacturer Sinalbin manufacturer 2,3-Diethyl-5-methylpyrazine manufacturer [[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester manufacturer